Company
Headquarters: Goleta, CA, United States
Employees: 1,021
CEO: Mr. Nabil Shabshab
$180.0 Million
USD as of Jan. 1, 2026
| Company | Market Cap (USD) |
|---|---|
| Abbott | $216.15 B |
| Boston Scientific Corporation | $140.40 B |
| Stryker | $133.15 B |
| Medtronic | $123.20 B |
| Edwards Lifesciences Corporation | $50.10 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
| Last Financial Reports Date | Dec. 31, 2023 |
| Revenue TTM | $315.7 M |
| EBITDA | $-45,679,000 |
| Gross Profit TTM | $126.7 M |
| Profit Margin | -32.46% |
| Operating Margin | -28.63% |
| Quarterly Revenue Growth | -13.80% |
Inogen, Inc. has the following listings and related stock indices.
Stock: NASDAQ: INGN
Stock: FSX: 6IO